Solution by iPASy
iPASy is developing an innovative diagnostic test based on urine.
Key features:
Non-invasive (no blood sample required)
Easy to use
More accurate than existing methods
May eliminate the need for additional testing
The technology focuses on a new way of analysing biomolecules associated with prostate cancer.
Technology and innovation
a. Glycobiomarkers
The test analyses changes in sugar molecules (glycosylation) on PSA proteins.
This provides better insight into:
the presence of cancer
tumour aggressiveness
b. PSA N-glycosylation analysis
Instead of only measuring PSA levels, iPASy examines the structure of PSA, providing more detailed diagnostic information.
c. Recombinant antibodies
The test uses modern biotechnology, resulting in:
